Growing community of inventors

Kandern, Germany

Dorothee Kling

Average Co-Inventor Count = 13.00

ph-index = 3

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 83

Dorothee KlingPaul Parren (6 patents)Dorothee KlingErhard Kopetzki (6 patents)Dorothee KlingJan Van De Winkel (6 patents)Dorothee KlingKay-Gunnar Stubenrauch (6 patents)Dorothee KlingBeat Steiner (6 patents)Dorothee KlingAnne Stern (6 patents)Dorothee KlingYvo Graus (6 patents)Dorothee KlingJacques Himber (6 patents)Dorothee KlingFrank Rebers (6 patents)Dorothee KlingMartine Van Vugt (6 patents)Dorothee KlingMiranda Jansen-Molenaar (6 patents)Dorothee KlingPamela Strein (4 patents)Dorothee KlingPamela Braemer (2 patents)Dorothee KlingDorothee Kling (6 patents)Paul ParrenPaul Parren (127 patents)Erhard KopetzkiErhard Kopetzki (58 patents)Jan Van De WinkelJan Van De Winkel (45 patents)Kay-Gunnar StubenrauchKay-Gunnar Stubenrauch (36 patents)Beat SteinerBeat Steiner (33 patents)Anne SternAnne Stern (26 patents)Yvo GrausYvo Graus (18 patents)Jacques HimberJacques Himber (14 patents)Frank RebersFrank Rebers (13 patents)Martine Van VugtMartine Van Vugt (13 patents)Miranda Jansen-MolenaarMiranda Jansen-Molenaar (6 patents)Pamela StreinPamela Strein (4 patents)Pamela BraemerPamela Braemer (2 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Hoffmann-la Roche Inc. (6 from 4,942 patents)


6 patents:

1. RE44389 - Methods of inhibiting the binding of P-selectin to PSGL-1 with anti-P-selectin antibodies

2. RE44359 - Nucleic acid molecules encoding anti-P-selectin antibodies

3. RE43568 - Anti-P-selectin antibodies

4. 7824684 - Methods of inhibiting the binding of P-selectin to PSGL-1 with anti-P-selectin antibodies

5. 7754867 - Nucleic acid molecules encoding anti-P-selectin antibodies

6. 7563441 - Anti-P-selectin antibodies

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/8/2025
Loading…